Atlas Trials

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Clinical trial NCT06899529 · RECRUITING

Trial details

NCT number
NCT06899529
Sponsor
Christian Ophthalmic Surgery Expedition Network
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy - High Risk
Start date
2025-03-20
Primary completion
2027-03-20
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.